StockData
Calidi Biotherapeutics, Inc. logo

Calidi Biotherapeutics, Inc. (CLDI) stock

CLDINYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as CLDWW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 3/30
$0.56−0.04 (-7.07%)

Close on Nov 17, 2026Market cap $1.45MP/E –Yield –

Calidi Biotherapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Calidi Biotherapeutics's price to book ratio was 0.4× on Nov 11, 2026, against 24.1× a year earlier.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.4×−18.2
2025Dec 31, 202518.7×–

More Calidi Biotherapeutics figures

See a number that looks wrong?